Kivu Bioscience Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$92M
- Investors
-
7
Kivu Bioscience General Information
Description
Developer of antibody-drug conjugates designed to improve the accuracy and safety of cancer treatment. The company offers proprietary ADC technologies that use site-specific conjugation, stable linkers, and potent payloads, enabling researchers and clinicians to develop targeted therapies with reduced off-target effects.
Contact Information
Website
www.kivubioscience.comCorporate Office
- 2929 Campus Drive
- Suite 420
- San Mateo, CA 94403
- United States
Corporate Office
- 2929 Campus Drive
- Suite 420
- San Mateo, CA 94403
- United States
Kivu Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 28-Oct-2024 | $92M | Completed | Clinical Trials - Phase 1 |
Kivu Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Kivu Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kivu Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kivu Bioscience Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioGeneration Ventures | Venture Capital | Minority | ||
| Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | ||
| Gimv | PE/Buyout | Minority | ||
| HealthCap | Venture Capital | Minority | ||
| M Ventures | Corporate Venture Capital | Minority |
Kivu Bioscience FAQs
-
When was Kivu Bioscience founded?
Kivu Bioscience was founded in 2024.
-
Where is Kivu Bioscience headquartered?
Kivu Bioscience is headquartered in San Mateo, CA.
-
What is the size of Kivu Bioscience?
Kivu Bioscience has 26 total employees.
-
What industry is Kivu Bioscience in?
Kivu Bioscience’s primary industry is Drug Discovery.
-
Is Kivu Bioscience a private or public company?
Kivu Bioscience is a Private company.
-
What is the current valuation of Kivu Bioscience?
The current valuation of Kivu Bioscience is .
-
What is Kivu Bioscience’s current revenue?
The current revenue for Kivu Bioscience is .
-
How much funding has Kivu Bioscience raised over time?
Kivu Bioscience has raised $92M.
-
Who are Kivu Bioscience’s investors?
BioGeneration Ventures, Brabantse Ontwikkelings Maatschappij, Gimv, HealthCap, and M Ventures are 5 of 7 investors who have invested in Kivu Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
